Stocks · Health care · Biological Products, (No Diagnostic Substances)

Aura Biosciences, Inc.

AURA Clue Score20
United States Fiscal year ends December CIK 0001501796 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Anthony S Gibney
16 Jun 2026
See Remarks
Sell
12,824
$6.42
$82.33K
Matrix Capital Management Company, LP
7 May 2026
10% owner
Sell indirect
6,922,870
$5.64
$39.04M
Conor Kilroy
16 Apr 2026
See Remarks
Sell
11,738
$7.02
$82.40K
los Pinos Elisabet de
17 Feb 2026
See Remarks
Sell
47,648
$5.06
$241.10K
Amy Elazzouzi
17 Feb 2026
Senior Vice President, Finance
Sell
8,549
$5.06
$43.26K
Janet Jill Hopkins
17 Feb 2026
Chief Medical Officer
Sell
20,401
$5.06
$103.23K
Mark Plavsic
17 Feb 2026
Chief Technology Officer
Sell
15,890
$5.05
$80.24K
Conor Kilroy
17 Feb 2026
See Remarks
Sell
12,079
$5.05
$61.00K
los Pinos Elisabet de
20 Jan 2026
See Remarks
Sell
16,928
$4.86
$82.27K
Amy Elazzouzi
20 Jan 2026
Senior Vice President, Finance
Sell
1,581
$4.86
$7.68K
Janet Jill Hopkins
17 Nov 2025
Chief Medical Officer
Sell
17,109
$5.42
$92.73K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 2,179,726
History held since 29 Oct 2021